The Oligonucleotide Therapeutics Society aims to foster academia and industry-based research and development of oligonucleotide therapeutics. The society envisions a new era of oligonucleotide drugs that vastly impacts therapeutic modalities, much like antibodies have revolutionized human therapeutics.
The Regional Delivery Grants program by the Oligonucleotide Therapeutics Society aims to extend the reach of OTS by supporting larger meetings in new locations beyond its traditional annual meetings in the US, Europe, and Canada. These grants are intended to facilitate knowledge sharing, professional development, and networking among researchers in the field of oligonucleotide therapeutics. By encouraging a variety of event formats—from symposia and networking events to seminar series and workshops—the grants program seeks to foster creativity, support a diverse range of professional activities, and particularly aid junior scientists and those focusing on diversity within the field. Grant applications are reviewed bi-annually on a rolling basis, with funding decisions made based on the benefits to the oligonucleotide research community.